- Home
- CCM vs NNVC Comparison
CCM vs NNVC Comparison
Compare CCM & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- NNVC
- Stock Information
- Founded
- CCM 1997
- NNVC 2005
- Country
- CCM China
- NNVC United States
- Employees
- CCM N/A
- NNVC N/A
- Industry
- CCM Medical/Nursing Services
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- NNVC Health Care
- Exchange
- CCM Nasdaq
- NNVC Nasdaq
- Market Cap
- CCM 20.4M
- NNVC 22.0M
- IPO Year
- CCM 2009
- NNVC N/A
- Fundamental
- Price
- CCM $4.70
- NNVC $1.19
- Analyst Decision
- CCM
- NNVC Strong Buy
- Analyst Count
- CCM 0
- NNVC 1
- Target Price
- CCM N/A
- NNVC $6.50
- AVG Volume (30 Days)
- CCM 15.7K
- NNVC 622.6K
- Earning Date
- CCM 09-27-2024
- NNVC 02-12-2025
- Dividend Yield
- CCM N/A
- NNVC N/A
- EPS Growth
- CCM N/A
- NNVC N/A
- EPS
- CCM N/A
- NNVC N/A
- Revenue
- CCM $64,910,622.00
- NNVC N/A
- Revenue This Year
- CCM N/A
- NNVC N/A
- Revenue Next Year
- CCM N/A
- NNVC N/A
- P/E Ratio
- CCM N/A
- NNVC N/A
- Revenue Growth
- CCM N/A
- NNVC N/A
- 52 Week Low
- CCM $3.80
- NNVC $1.01
- 52 Week High
- CCM $26.70
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- CCM 47.65
- NNVC 33.37
- Support Level
- CCM $4.42
- NNVC $1.42
- Resistance Level
- CCM $5.09
- NNVC $1.65
- Average True Range (ATR)
- CCM 1.07
- NNVC 0.11
- MACD
- CCM -0.02
- NNVC -0.04
- Stochastic Oscillator
- CCM 11.67
- NNVC 13.21
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.